Comparison of MRI radiomics-based machine learning survival models in predicting prognosis of glioblastoma multiforme

被引:2
|
作者
Zhang, Di [1 ]
Luan, Jixin [2 ,3 ]
Liu, Bing [2 ,3 ]
Yang, Aocai [2 ,3 ]
Lv, Kuan [4 ]
Hu, Pianpian [4 ]
Han, Xiaowei [5 ]
Yu, Hongwei [3 ]
Shmuel, Amir [6 ,7 ]
Ma, Guolin [3 ]
Zhang, Chuanchen [1 ]
机构
[1] Shandong First Med Univ & Shandong Acad Med Sci, Liaocheng Peoples Hosp, Dept Radiol, Liaocheng, Shandong, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Dept Radiol, Beijing, Peoples R China
[4] Peking Univ, China Japan Friendship Sch Clin Med, Beijing, Peoples R China
[5] Nanjing Univ, Affiliated Drum Tower Hosp, Med Sch, Dept Radiol, Nanjing, Peoples R China
[6] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada
[7] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada
基金
中国国家自然科学基金;
关键词
glioblastoma multiforme; radiomics; machine learning; survival models; prognosis;
D O I
10.3389/fmed.2023.1271687
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo compare the performance of radiomics-based machine learning survival models in predicting the prognosis of glioblastoma multiforme (GBM) patients.Methods131 GBM patients were included in our study. The traditional Cox proportional-hazards (CoxPH) model and four machine learning models (SurvivalTree, Random survival forest (RSF), DeepSurv, DeepHit) were constructed, and the performance of the five models was evaluated using the C-index.ResultsAfter the screening, 1792 radiomics features were obtained. Seven radiomics features with the strongest relationship with prognosis were obtained following the application of the least absolute shrinkage and selection operator (LASSO) regression. The CoxPH model demonstrated that age (HR = 1.576, p = 0.037), Karnofsky performance status (KPS) score (HR = 1.890, p = 0.006), radiomics risk score (HR = 3.497, p = 0.001), and radiomics risk level (HR = 1.572, p = 0.043) were associated with poorer prognosis. The DeepSurv model performed the best among the five models, obtaining C-index of 0.882 and 0.732 for the training and test set, respectively. The performances of the other four models were lower: CoxPH (0.663 training set / 0.635 test set), SurvivalTree (0.702/0.655), RSF (0.735/0.667), DeepHit (0.608/0.560).ConclusionThis study confirmed the superior performance of deep learning algorithms based on radiomics relative to the traditional method in predicting the overall survival of GBM patients; specifically, the DeepSurv model showed the best predictive ability.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Differentiating Glioblastoma Multiforme from Brain Metastases Using Multidimensional Radiomics Features Derived from MRI and Multiple Machine Learning Models
    Bijari, Salar
    Jahanbakhshi, Amin
    Hajishafiezahramini, Parham
    Abdolmaleki, Parviz
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [22] Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques
    Girish Bathla
    Sarv Priya
    Yanan Liu
    Caitlin Ward
    Nam H. Le
    Neetu Soni
    Ravishankar Pillenahalli Maheshwarappa
    Varun Monga
    Honghai Zhang
    Milan Sonka
    European Radiology, 2021, 31 : 8703 - 8713
  • [23] Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques
    Bathla, Girish
    Priya, Sarv
    Liu, Yanan
    Ward, Caitlin
    Le, Nam H.
    Soni, Neetu
    Maheshwarappa, Ravishankar Pillenahalli
    Monga, Varun
    Zhang, Honghai
    Sonka, Milan
    EUROPEAN RADIOLOGY, 2021, 31 (11) : 8703 - 8713
  • [24] Machine learning for multi-parametric breast MRI: radiomics-based approaches for lesion classification
    Altabella, Luisa
    Benetti, Giulio
    Camera, Lucia
    Cardano, Giuseppe
    Montemezzi, Stefania
    Cavedon, Carlo
    PHYSICS IN MEDICINE AND BIOLOGY, 2022, 67 (15):
  • [25] RADIOMICS-BASED MODEL PREDICTIVE OF OVERALL SURVIVAL IN GLIOBLASTOMA USING MULTI-INSTITUTIONAL PREOPERATIVE MRI SCANS
    Kowalchuk, Roman
    Conte, Gian Marco
    Crompton, David
    Cabreja, Ricardo Domingo
    Vega, Carlos Perez
    Moassefi, Mana
    Faghani, Shahriar
    Khosravi, Bardia
    Vora, Sujay
    Erickson, Bradley
    Trifiletti, Daniel
    NEURO-ONCOLOGY, 2022, 24 : 183 - 183
  • [26] MRI Radiomics-Based Machine Learning Models for Ki67 Expression and Gleason Grade Group Prediction in Prostate Cancer
    Qiao, Xiaofeng
    Gu, Xiling
    Liu, Yunfan
    Shu, Xin
    Ai, Guangyong
    Qian, Shuang
    Liu, Li
    He, Xiaojing
    Zhang, Jingjing
    CANCERS, 2023, 15 (18)
  • [27] Radiomics-based survival risk stratification of glioblastoma is associated with different genome alteration
    Xu, Peng-Fei
    Li, Cong
    Chen, Yin-Sheng
    Li, De-Pei
    Xi, Shao-Yan
    Chen, Fu-Rong
    Li, Xin
    Chen, Zhong-Ping
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 159
  • [28] A Comparative and Summative Study of Radiomics-based Overall Survival Prediction in Glioblastoma Patients
    Ruan, Zhuoying
    Mei, Nan
    Lu, Yiping
    Xiong, Ji
    Li, Xuanxuan
    Zheng, Weiwei
    Liu, Li
    Yin, Bo
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2022, 46 (03) : 470 - 479
  • [29] Comparison of Feature Selection Methods and Machine Learning Classifiers with CT Radiomics-Based Features for Predicting Chronic Obstructive Pulmonary Disease
    Makimoto, K.
    Au, R. C.
    Moslemi, A.
    Hogg, J. C.
    Bourbeau, J.
    Tan, W. C.
    Kirby, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [30] Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time
    Liao, Xin
    Cai, Bo
    Tian, Bin
    Luo, Yilin
    Song, Wen
    Li, Yinglong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (06) : 4375 - 4385